Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Brain Damage, Chronic

n(g),n(g')-dimethyl-l-arginine has been researched along with Brain Damage, Chronic in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Notsu, Y1
Nabika, T1
Bokura, H1
Suyama, Y1
Kobayashi, S1
Yamaguchi, S1
Masuda, J1

Other Studies

1 other study available for n(g),n(g')-dimethyl-l-arginine and Brain Damage, Chronic

ArticleYear
Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
    American journal of hypertension, 2009, Volume: 22, Issue:3

    Topics: Arginine; Arteriosclerosis; Biomarkers; Blood Pressure; Brain Damage, Chronic; Cerebral Infarction;

2009